// App-Quantinova.ai

AB0668 (2022) : ASYMMETRICAL DIMETHYLARGININE CORRELATES WITH WORSENING PERIPHERAL MICROANGIOPATHY IN SYSTEMIC SCLEROSIS

Researchers

Presenter

  • E. Pagkopoulou

Principal Investigators

  • S. Soulaidopoulos

  • E. Triantafyllidou

  • G. Kitas

  • A. Garyfallos

  • T. Dimitroulas

Medical Centers

  • Hippokration Hospital, Aristotle University of Thessaloniki, Fourth Department of Internal Medicine, Thessaloniki, Greece

  • Hippokration General Hospital, National and Kapodistrian University of Athens, First Department of Cardiology, Athina, Greece

  • Dudley Group of Hospitals, NS Foundation Trust, Dudley, United Kingdom, Department of Rheumatology,, Dudley, United Kingdom

  • University of Manchester, Manchester, United Kingdom, Arthritis Research UK Centre for Epidemiology, Manchester, United Kingdom

Locations

  • Greece

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • Asymmetric Dimethylarginine

Drug/Treatment

  • AVIVA

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved